ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 397,57
-0,48%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Immuron Ltd (IMRN)

  7. Immuron Ltd (IMRN) Actualités

IMRN

Immuron (IMRN)

Immuron Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IMRN
DateHeureSourceTitreSymboleSociété
31/05/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
31/05/202412h00GlobeNewswire Inc.Immuron Board ChangesNASDAQ:IMRNImmuron Ltd
31/05/202412h00GlobeNewswire Inc.Immuron CEO Steven Lydeamore to present at Peak Sky HighNASDAQ:IMRNImmuron Ltd
03/05/202412h00GlobeNewswire Inc.Immuron Director ResignationNASDAQ:IMRNImmuron Ltd
15/04/202412h00GlobeNewswire Inc.Immuron to host Live Virtual EventNASDAQ:IMRNImmuron Ltd
10/04/202412h00GlobeNewswire Inc.Immuron Travelan® sales continued strong growthNASDAQ:IMRNImmuron Ltd
07/03/202412h00GlobeNewswire Inc.Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USNASDAQ:IMRNImmuron Ltd
21/02/202412h00GlobeNewswire Inc.Immuron Presentation Australian Biologics Festival 2024NASDAQ:IMRNImmuron Ltd
13/02/202412h00GlobeNewswire Inc.Immuron achieves record Travelan® salesNASDAQ:IMRNImmuron Ltd
08/02/202412h00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
16/01/202412h00GlobeNewswire Inc.Immuron achieves record half yearly Travelan® salesNASDAQ:IMRNImmuron Ltd
22/12/202312h00GlobeNewswire Inc.Immuron Clinical Trials UpdateNASDAQ:IMRNImmuron Ltd
04/12/202312h00GlobeNewswire Inc.Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyNASDAQ:IMRNImmuron Ltd
14/11/202300h00GlobeNewswire Inc.Immuron CEO Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
30/10/202312h21GlobeNewswire Inc.Immuron CEO Steven Lydeamore presented at AusBioInvestNASDAQ:IMRNImmuron Ltd
18/10/202312h00GlobeNewswire Inc.Immuron Announces Travelan® Clinical Study Cohort 2 commencesNASDAQ:IMRNImmuron Ltd
11/10/202312h00GlobeNewswire Inc.Immuron achieves record quarterly Travelan® salesNASDAQ:IMRNImmuron Ltd
28/09/202312h18Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:IMRNImmuron Ltd
13/09/202312h00GlobeNewswire Inc.Immuron achieves record monthly Travelan® salesNASDAQ:IMRNImmuron Ltd
11/09/202312h00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to present at H.C. WainwrightNASDAQ:IMRNImmuron Ltd
14/08/202312h00GlobeNewswire Inc.Immuron to present at the Military Health System Research SymposiumNASDAQ:IMRNImmuron Ltd
25/07/202312h00GlobeNewswire Inc.Immuron Announces First Patients Enrolled in Travelan® Clinical StudyNASDAQ:IMRNImmuron Ltd
24/07/202312h00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to present at BiosharesNASDAQ:IMRNImmuron Ltd
11/07/202312h00GlobeNewswire Inc.Immuron Business Update - Ateria Health launches Juvia™ in AustraliaNASDAQ:IMRNImmuron Ltd
05/07/202312h00GlobeNewswire Inc.Immuron FY23 Sales increase 136% on FY22 SalesNASDAQ:IMRNImmuron Ltd
30/06/202312h00GlobeNewswire Inc.Immuron Chairman TransitionNASDAQ:IMRNImmuron Ltd
22/06/202312h00GlobeNewswire Inc.Immuron Business Update: Letter to ShareholdersNASDAQ:IMRNImmuron Ltd
07/06/202314h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMRNImmuron Ltd
30/05/202312h00GlobeNewswire Inc.Immuron Initiates Recruitment of Travelan® Clinical StudyNASDAQ:IMRNImmuron Ltd
08/05/202316h25AllPennyStocks.comBiotech Shares Already Bid Up During Monday's PremarketNASDAQ:IMRNImmuron Ltd
 Showing the most relevant articles for your search:NASDAQ:IMRN

Dernières Valeurs Consultées

LSE
MGHZ
EU
RNAAF
REG Nouv Aquit 0.439% 22...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés